Jeffrey M. Drazen, M.D. - Publications

Affiliations: 
Environmental Health Harvard University, Cambridge, MA, United States 
Area:
Environmental Health
Website:
https://www.hsph.harvard.edu/jeffrey-drazen/

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, et al. Erratum: The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma (International Archives of Allergy and Immunology (2000) 162 (75-80)) International Archives of Allergy and Immunology. 157. DOI: 10.1159/000335957  0.362
2003 Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C, Laird NM, Weiss ST. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. The Journal of Allergy and Clinical Immunology. 112: 870-6. PMID 14610472 DOI: 10.1016/S0091-6749(03)02023-2  0.343
2003 Shore SA, Drazen JM. Beta-agonists and asthma: too much of a good thing? The Journal of Clinical Investigation. 112: 495-7. PMID 12925688 DOI: 10.1172/Jci19642  0.329
2002 Tschumperlin DJ, Shively JD, Swartz MA, Silverman ES, Haley KJ, Raab G, Drazen JM. Bronchial epithelial compression regulates MAP kinase signaling and HB-EGF-like growth factor expression. American Journal of Physiology. Lung Cellular and Molecular Physiology. 282: L904-11. PMID 11943653 DOI: 10.1152/ajplung.00270.2001  0.312
2001 Wang Z, Chen C, Niu T, Wu D, Yang J, Wang B, Fang Z, Yandava CN, Drazen JM, Weiss ST, Xu X. Association of asthma with β2-adrenergic receptor gene polymorphism and cigarette smoking American Journal of Respiratory and Critical Care Medicine. 163: 1404-1409. PMID 11371409 DOI: 10.1164/Ajrccm.163.6.2001101  0.33
2001 Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. Jama. 285: 2583-93. PMID 11368732 DOI: 10.1001/Jama.285.20.2583  0.349
2001 Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, et al. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. International Archives of Allergy and Immunology. 124: 183-6. PMID 11306963 DOI: 10.1159/000053705  0.343
2000 Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. American Journal of Respiratory and Critical Care Medicine. 162: 75-80. PMID 10903223 DOI: 10.1164/Ajrccm.162.1.9907092  0.337
Show low-probability matches.